FEDERAL TRADE COMMISSION v. CARIS LIFE SCIENCES, INC.
Case Number:
1:21-mc-00115
Court:
Nature of Suit:
Judge:
Firms
Companies
Government Agencies
Sectors & Industries:
-
June 09, 2022
FTC Judge Says Lives At Stake In Cancer Test Deal Challenge
Federal Trade Commission staffers pressed their bid to block Illumina's $8 billion reacquisition of cancer testing outfit Grail during closing arguments, as the agency's administrative law judge questioned whether getting the case wrong could cost lives.
-
February 11, 2022
FTC No Longer Pressing For Caris Docs In Illumina Case
A D.C. federal judge on Friday granted the Federal Trade Commission's request to put on ice a lawsuit the agency filed demanding that Caris Life Sciences comply with subpoenas in the FTC's challenge to the planned merger of biotech firms Illumina and Grail.
-
December 02, 2021
FTC Pushing Caris Life Sciences For Merger Challenge Docs
Caris Life Sciences is fighting a subpoena in connection with the Federal Trade Commission's challenge of the Illumina-Grail deal, arguing the broad scope of the requests puts its trade secrets at risk.